Hugh S Taylor MD
Reproductive Endocrinology & Infertility
Anita O'Keeffe Young Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine
Join to View Full Profile
150 Sargent DrSte 2Orange, CT 06511
Phone+1 203-785-4708
Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hugh Taylor is an obstetrician/gynecologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from University of Connecticut School of Medicine and has been in practice 29 years. He specializes in reproductive endocrinology & infertility and is experienced in endometriosis, infertility, fibroids, Asherman syndrome and menopause.
He is currently Professor and Chair of Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine.
Education & Training
Yale-New Haven Medical CenterFellowship, Reproductive Endocrinology and Infertility, 1993 - 1996- Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1988 - 1992
Uconn School Of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 2020 - 2026
CT State Medical License 1991 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Awards, Honors, & Recognition
- Association of American Physicians 2024
- IVI International Award
- National Academy of Medicine. 2016
- Join now to see all
Clinical Trials
- KEEPS Cognitive and Affective Study Start of enrollment: 2007 May 01
- Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium Start of enrollment: 2023 Nov 01
Roles: Contact, Sponsor-Investigator, Principal Investigator
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain Start of enrollment: 2022 Oct 25
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Observational and Genetic Analyses of Traumatic Experiences and Endometriosis.Dora Koller, Solveig Løkhammer, Oksana Goroshchuk, Veronika Denner, Brendan Stiltner
JAMA Psychiatry. 2025-04-01 - Effect of single vs double-blind peer review: a difference-in-difference analysis.Rula Atwani, Carole Barake, Misooja Lee, George Saade, Hugh Taylor
American Journal of Obstetrics & Gynecology MFM. 2025-03-01 - Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole ...Jeremy J Johnson, Hiba Siblini, Ayman Al-Hendy, James H Segars, Frank González
Clinical and Translational Science. 2025-03-01
Journal Articles
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologySerdar E Bulun, Kristen A Matteson, Hugh S Taylor, American Journal of Obstetrics and Gynecology
- Progesterone Receptor Status Predicts Response to Progestin Therapy in EndometriosisValerie A Flores, Hugh S Taylor, The Journal of Clinical Endocrinology and Metabolism
Authored Content
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologyJuly 2020
- "Menstruation: Science and Society" - American Journal of Obstetrics & GynecologyJuly 2020
Press Mentions
Study Reveals ‘Strong Genetic Connection’ Between Period Pain and DepressionNovember 29th, 2024- 5 Questions with Hugh S. Taylor, MDNovember 11th, 2024
- Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy DesignationOctober 24th, 2024
- Join now to see all
Grant Support
- Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy lossYALE UNIVERSITY2021–2026
- Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4YALE UNIVERSITY2019–2025
- Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4YALE UNIVERSITY2019–2025
- The Yale WRHR Career Development CenterYALE UNIVERSITY2004–2025
- Project 1Eunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Alteration Of HOX Gene Expression By Endocrine Disrupting ChemicalsNational Institute Of Environmental Health Sciences2007–2011
- Contribution Of Adult Bone Marrow-Derived Stem Cells To EndometriumEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
- Center For Endometrial Biology And EndometriosisEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
- Administrtive CellsEunice Kennedy Shriver National Institute Of Child Health &Human Development2007
- HOX Gene Expression In Human EndometriumEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
- HOX Gene Expression By Endocrine Disrupting ChemicalsNational Institute Of Environmental Health Sciences2001–2005
- HOX Gene Expression In Human EndometriumEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
- Determination Of Homeobox Gene SpecificityEunice Kennedy Shriver National Institute Of Child Health &Human Development1993–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
